Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1904 1
1915 1
1924 3
1927 2
1928 6
1931 1
1933 1
1935 3
1940 2
1944 1
1946 5
1947 5
1949 3
1950 2
1951 2
1952 2
1953 7
1954 4
1955 8
1956 2
1957 4
1958 4
1959 9
1960 9
1961 10
1962 6
1963 12
1964 15
1965 5
1966 5
1967 7
1968 13
1969 27
1970 20
1971 27
1972 28
1973 28
1974 43
1975 109
1976 93
1977 106
1978 97
1979 81
1980 83
1981 81
1982 105
1983 149
1984 180
1985 183
1986 138
1987 153
1988 175
1989 197
1990 156
1991 163
1992 159
1993 189
1994 216
1995 268
1996 256
1997 277
1998 373
1999 445
2000 484
2001 550
2002 555
2003 660
2004 795
2005 1044
2006 1226
2007 1419
2008 1499
2009 1569
2010 1542
2011 1688
2012 1794
2013 1882
2014 2136
2015 2351
2016 2426
2017 2441
2018 2422
2019 2384
2020 2909
2021 3217
2022 3020
2023 2819
2024 1209

Text availability

Article attribute

Article type

Publication date

Search Results

43,361 results

Results by year

Filters applied: . Clear all
Page 1
Age-Related Macular Degeneration.
Thomas CJ, Mirza RG, Gill MK. Thomas CJ, et al. Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2. Med Clin North Am. 2021. PMID: 33926642 Free article. Review.
Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age, with the severity of vision loss ranging from mild to severe. ...
Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age
Age-related macular degeneration.
Guymer RH, Campbell TG. Guymer RH, et al. Lancet. 2023 Apr 29;401(10386):1459-1472. doi: 10.1016/S0140-6736(22)02609-5. Epub 2023 Mar 27. Lancet. 2023. PMID: 36996856 Review.
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. ...Advances in retinal imaging have identified biomarkers of progression to late age-related macular
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and
Age-related macular degeneration.
Mitchell P, Liew G, Gopinath B, Wong TY. Mitchell P, et al. Lancet. 2018 Sep 29;392(10153):1147-1159. doi: 10.1016/S0140-6736(18)31550-2. Lancet. 2018. PMID: 30303083 Review.
Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. ...Intravitreal anti-vascular endothelial growth factor therapy (eg, ranibizumab, aflibercept, or bevacizumab) is highly effective at treating neovascular
Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. ...Intravitreal
The Diagnosis and Treatment of Age-Related Macular Degeneration.
Stahl A. Stahl A. Dtsch Arztebl Int. 2020 Jul 20;117(29-30):513-520. doi: 10.3238/arztebl.2020.0513. Dtsch Arztebl Int. 2020. PMID: 33087239 Free PMC article. Review.
BACKGROUND: Age-related macular degeneration (AMD) is thought to cause approximately 9% of all cases of blindness worldwide. ...The early stage is often asymptomatic; patients in the other two stages often have distorted vision or central visual field …
BACKGROUND: Age-related macular degeneration (AMD) is thought to cause approximately 9% of all cases of blindnes …
Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives.
Flores R, Carneiro Â, Vieira M, Tenreiro S, Seabra MC. Flores R, et al. Ophthalmologica. 2021;244(6):495-511. doi: 10.1159/000517520. Epub 2021 Jun 15. Ophthalmologica. 2021. PMID: 34130290 Free article. Review.
Among older adults, age-related macular degeneration (AMD) is a prevalent disabling condition that begins as subtle visual disturbances and can progress to permanent loss of central vision. ...
Among older adults, age-related macular degeneration (AMD) is a prevalent disabling condition that begins as sub …
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).
Nashine S. Nashine S. Cells. 2021 Sep 19;10(9):2483. doi: 10.3390/cells10092483. Cells. 2021. PMID: 34572131 Free PMC article. Review.
Aging contributes to the risk of development of ocular diseases including, but not limited to, Age-related Macular Degeneration (AMD) that is a leading cause of blindness in the United States as well as worldwide. ...
Aging contributes to the risk of development of ocular diseases including, but not limited to, Age-related Macular D
AGE-RELATED MACULAR DEGENERATION.
Gheorghe A, Mahdi L, Musat O. Gheorghe A, et al. Rom J Ophthalmol. 2015 Apr-Jun;59(2):74-7. Rom J Ophthalmol. 2015. PMID: 26978865 Free PMC article. Review.
SYSTEMATIC REVIEW METHODOLOGY: Relevant publications on Age-Related Macular Degeneration that were published until 2014. CONCLUSIONS: Age-related macular degeneration (AMD) is a common macular disease affecting elderl …
SYSTEMATIC REVIEW METHODOLOGY: Relevant publications on Age-Related Macular Degeneration that were published unt …
Age-related macular degeneration.
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Lim LS, et al. Lancet. 2012 May 5;379(9827):1728-38. doi: 10.1016/S0140-6736(12)60282-7. Lancet. 2012. PMID: 22559899 Review.
Age-related macular degeneration is a major cause of blindness worldwide. With ageing populations in many countries, more than 20% might have the disorder. Advanced age-related macular degeneration, including neovascular
Age-related macular degeneration is a major cause of blindness worldwide. With ageing populations in many countr
The complement system in age-related macular degeneration.
Armento A, Ueffing M, Clark SJ. Armento A, et al. Cell Mol Life Sci. 2021 May;78(10):4487-4505. doi: 10.1007/s00018-021-03796-9. Epub 2021 Mar 9. Cell Mol Life Sci. 2021. PMID: 33751148 Free PMC article. Review.
Age-related macular degeneration (AMD) is a chronic and progressive degenerative disease of the retina, which culminates in blindness and affects mainly the elderly population. ...
Age-related macular degeneration (AMD) is a chronic and progressive degenerative disease of the retina, which cu
Review of gene therapies for age-related macular degeneration.
Khanani AM, Thomas MJ, Aziz AA, Weng CY, Danzig CJ, Yiu G, Kiss S, Waheed NK, Kaiser PK. Khanani AM, et al. Eye (Lond). 2022 Feb;36(2):303-311. doi: 10.1038/s41433-021-01842-1. Epub 2022 Jan 11. Eye (Lond). 2022. PMID: 35017696 Free PMC article. Review.
We present the available data of current clinical trials for the treatment of neovascular and dry age-related macular degeneration with different AAV-based gene therapies. ...Retinal gene therapies offer the potential for life-changing treatment for ch …
We present the available data of current clinical trials for the treatment of neovascular and dry age-related macular
43,361 results
You have reached the last available page of results. Please see the User Guide for more information.